FDA Approves, Cobenfy, a New Kind of Drug for Schizophrenia
FRIDAY, Sept. 27, 2024 -- The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.
Cobenfy (xanomeline/trospium chloride) could bring patients what they've...